Distribution of Cervical Lymph Node Metastases From Squamous Cell Carcinoma of the Oropharynx in the Era of Risk Stratification Using Human Papillomavirus and Smoking Status

被引:33
作者
Amsbaugh, Mark J. [1 ]
Yusuf, Mehran [1 ]
Cash, Elizabeth [2 ]
Silverman, Craig [1 ]
Wilson, Elizabeth [2 ]
Bumpous, Jeffrey [2 ]
Potts, Kevin [2 ]
Perez, Cesar [3 ]
Bert, Robert [4 ]
Redman, Rebecca [3 ]
Dunlap, Neal [1 ]
机构
[1] Univ Louisville, Dept Radiat Oncol, 529 South Jackson St, Louisville, KY 40202 USA
[2] Univ Louisville, Dept Otolaryngol, Louisville, KY 40292 USA
[3] Univ Louisville, Dept Med, Div Med Oncol, Louisville, KY 40292 USA
[4] Univ Louisville, Dept Diagnost Radiol, Louisville, KY 40292 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词
CANCER; IMPACT; HEAD;
D O I
10.1016/j.ijrobp.2016.06.2450
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose/Objective(s): To investigate the factors contributing to the clinical presentation of oropharyngeal squamous cell carcinoma (OPSCC) in the era of risk stratification using human papilloma virus (HPV) and smoking status. Methods and Materials: All patients with OPSCC presenting to our institutional multidisciplinary clinic from January 2009 to June 2015 were reviewed from a prospective database. The patients were grouped as being at low risk, intermediate risk, and high risk in the manner described by Ang et al. Variance in clinical presentation was examined using chi(2), Kruskal-Wallis, Mann-Whitney, and logistic regression analyses. Results: The rates of HPV/p16 positivity (P <. 001), never-smoking (P =. 016), and cervical lymph node metastases (P =. 023) were significantly higher for patients with OPSCC of the tonsil, base of tongue (BOT), or vallecula subsites when compared with pharyngeal wall or palate subsites. Low-risk patients with tonsil, base of tongue, or vallecula primary tumors presented with nodal stage N2a at a much higher than expected frequency (P =. 007), and high-risk patients presented with tumor stage T4 at a much higher than expected frequency (P = .003). Patients with BOT primary tumors who were never-smokers were less likely to have clinically involved ipsilateral neck disease than were former smokers (odds ratio 1.8; P =. 038). The distribution of cervical lymph node metastases was not associated with HPV/p16 positivity, risk group, or subsite. When these data were compared with those in historical series, no significant differences were seen in the patterns of cervical lymph node metastases for patients with OPSCC. Conclusions: For patients with OPSCC differences in HPV status, smoking history and anatomic subsite were associated with differences in clinical presentation but not with distribution of cervical lymph node metastases. Historical series describing the patterns of cervical lymph node metastases in patients with OPSCC remain clinically relevant. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:349 / 353
页数:5
相关论文
共 10 条
  • [1] Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
    Ang, K. Kian
    Harris, Jonathan
    Wheeler, Richard
    Weber, Randal
    Rosenthal, David I.
    Nguyen-Tan, Phuc Felix
    Westra, William H.
    Chung, Christine H.
    Jordan, Richard C.
    Lu, Charles
    Kim, Harold
    Axelrod, Rita
    Silverman, C. Craig
    Redmond, Kevin P.
    Gillison, Maura L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) : 24 - 35
  • [2] The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas
    Benson, Eleni
    Li, Ryan
    Eisele, David
    Fakhry, Carole
    [J]. ORAL ONCOLOGY, 2014, 50 (06) : 565 - 574
  • [3] Cannon G, 2015, CLIN RAD ONCOLOGY
  • [4] Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States
    Chaturvedi, Anil K.
    Engels, Eric A.
    Anderson, William F.
    Gillison, Maura L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 612 - 619
  • [5] Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers
    Gillison, Maura L.
    D'Souza, Gypsyamber
    Westra, William
    Sugar, Elizabeth
    Xiao, Weihong
    Begum, Shahnaz
    Viscidi, Raphael
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (06): : 407 - 420
  • [6] LINDBERG R, 1972, CANCER, V29, P1446, DOI 10.1002/1097-0142(197206)29:6<1446::AID-CNCR2820290604>3.0.CO
  • [7] 2-C
  • [8] Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancersystematic review and meta-analysis of trends by time and region
    Mehanna, Hisham
    Beech, Tom
    Nicholson, Tom
    El-Hariry, Iman
    McConkey, Christopher
    Paleri, Vinidh
    Roberts, Sally
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (05): : 747 - 755
  • [9] Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
    Rischin, Danny
    Young, Richard J.
    Fisher, Richard
    Fox, Stephen B.
    Le, Quynh-Thu
    Peters, Lester J.
    Solomon, Ben
    Choi, Jimin
    O'Sullivan, Brian
    Kenny, Lizbeth M.
    McArthur, Grant A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) : 4142 - 4148
  • [10] Distribution and impact of lymph node metastases in oropharyngeal cancer
    Shimizu, Ken-Ichiro
    Inoue, Hiroyuki
    Saitoh, Miki
    Ohtsuki, Naoki
    Ishida, Haruhiko
    Makino, Kunihiko
    Amatsu, Mutsuo
    Nibu, Ken-ichi
    [J]. ACTA OTO-LARYNGOLOGICA, 2006, 126 (08) : 872 - 877